Latest Articles

Publication Date
Endometrial Cancer Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer, AbilityPharma, Eisai Co Ltd - openPR

Endometrial Cancer Market Size, Share, Growth Insights and Report 2024-2031 | Pfizer, AbilityPharma, Eisai Co Ltd openPR

Published: Oct. 15, 2024, 12:47 p.m.
Melanoma Cell Adhesion Molecule (CD 146) in Endometrial Physiology and Disorder.

The human endometrium, the innermost lining of the uterus, is the anatomic prerequisite for pregnancy. It is the only dynamic tissue that undergoes more than 400 cycles of regeneration throughout …

Published: Oct. 15, 2024, midnight
New Innovations in Endometrial Cancer Market Technology: - openPR

New Innovations in Endometrial Cancer Market Technology: openPR

Published: Oct. 14, 2024, 12:16 p.m.
Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer:A Minireview - Frontiers

Progestin-based pharmacotherapy in fertility preservation in early endometrial cancer:A Minireview Frontiers

Published: Oct. 14, 2024, 11:09 a.m.
Clear Cell Carcinoma Arising From Adenomyotic Cyst: A Case Report.

Clear cell carcinoma often arises from endometriosis, primarily from ovarian chocolate cysts and much less frequently from adenomyosis. We herein report a case of clear cell carcinoma arising from adenomyotic …

Published: Oct. 14, 2024, midnight
Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.

Pyroptosis is an inflammatory cell death induced by inflammasomes that release several pro-inflammatory mediators such as interleukin-18 (IL-18) and interleukin-1β (IL-1β). Pyroptosis, a type of programmed cell death, has recently …

Published: Oct. 3, 2024, midnight
History of infertility and risk of endometrial cancer in the Women's Health Initiative.

Several studies have suggested an association between infertility and risk of endometrial cancer. However, most studies have evaluated this relationship in premenopausal people, yet the mean age of endometrial cancer …

Published: Sept. 30, 2024, midnight
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.

Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, …

Published: Sept. 21, 2024, midnight
Zearalenone promotes endometrial cancer cell migration and invasion via activation of estrogen receptor-mediated Rho/ROCK/PMLC signaling pathway.

Zearalenone (ZEA), has emerged as a potential endocrine-disrupting chemical (EDC). Previous results show ZEA effects on endometrial stromal cell apoptosis, migration, and growth of endometriosis. Despite the reported presence of …

Published: Sept. 19, 2024, midnight
MSK Endometrial Cancer e-Tumor Board - Medscape

MSK Endometrial Cancer e-Tumor Board Medscape

Published: July 12, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!